Andrew Russman, DO: Neuroprotection Versus Neurorestoration

Video

The medical director of the Comprehensive Stroke Center at Cleveland Clinic detailed the differences between neuroprotection and neurorestoration, and the available options for each.

“There has been so much investment over time in these [neuroprotection] trials and none of them have really shown success. Neurorestoration may show more promise.”

Thrombolytic therapies are the primary method of neuroprotection for patients following acute ischemic stroke (AIS), with the goal of preventing the infarction from increasing in size. Other therapies, including cooling, have been tried; however, many of those therapies are likely not as effective as thrombolysis and thrombectomy.

Andrew Russman, DO, medical director of the Comprehensive Stroke Center at Cleveland Clinic, believes that neurorestoration may have more potential than neuroprotection, as it is aimed at regenerating tissue and reducing disability. This includes deep brain stimulation and cell therapies.

In an interview with NeurologyLive, Russman discussed why the pursuit of neurorestoration therapies may be a more viable option for improving long-term outcomes in patients with AIS.

Recent Videos
Kiran Musunuru, MD, PhD, a physician-scientist and Barry J. Gertz Professor for translational research in the Perelman School of Medicine at the University of Pennsylvania and CHOP and Rebecca Ahrens-Nicklas, MD, PhD, a physician-scientist and director of the Gene Therapy for Inherited Metabolic Disorders Frontier Program at CHOP
Nicholas Giovannone, PhD, a senior principal scientist at Regeneron
Nathan Yozwiak, PhD, on Collaboration for Cell and Gene Therapy Development
Cure SMA Treatment Recommendations
Cure SMA Treatment Recommendations
Cure SMA Treatment Recommendations
James Beck, PhD, the chief scientific officer of the Parkinson’s Foundation
James Beck, PhD, the chief scientific officer of the Parkinson’s Foundation
Linda Marbán, PhD, the CEO of Capricor Therapeutics
Cassandra Gorsuch, PhD, chief scientific officer at Precision
© 2025 MJH Life Sciences

All rights reserved.